230 related articles for article (PubMed ID: 37042078)
1. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
3. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
4. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
5. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
6. Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.
Giusti F; Cioppi F; Fossi C; Marini F; Masi L; Tonelli F; Brandi ML
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2110-e2123. PubMed ID: 34922358
[TBL] [Abstract][Full Text] [Related]
7. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
[TBL] [Abstract][Full Text] [Related]
8. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
9. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with Zollinger-Ellison syndrome.
Meko JB; Norton JA
Annu Rev Med; 1995; 46():395-411. PubMed ID: 7598474
[TBL] [Abstract][Full Text] [Related]
11. [Recent trend of diagnosis and treatment for Zollinger-Ellison syndrome].
Imamura M; Komoto I; Doi R
Gan To Kagaku Ryoho; 2005 Feb; 32(2):147-51. PubMed ID: 15751623
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
13. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
15. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma.
Wada M; Komoto I; Doi R; Imamura M
World J Surg; 2002 Oct; 26(10):1291-6. PubMed ID: 12205549
[TBL] [Abstract][Full Text] [Related]
16. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
18. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
[TBL] [Abstract][Full Text] [Related]
19. Gastrinoma--morphological aspects.
Klöppel G; Anlauf M
Wien Klin Wochenschr; 2007; 119(19-20):579-84. PubMed ID: 17985091
[TBL] [Abstract][Full Text] [Related]
20. [Which diagnostic and therapeutic approach to the Zollinger-Ellison syndrome should be adopted in 1990?].
Mignon M; Benhamou G
Acta Chir Belg; 1991; 91(2):88-95. PubMed ID: 1676864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
